Kazia Therapeutics (KZIA) Short Interest Ratio & Short Volume $0.88 -0.07 (-7.36%) Closing price 03/28/2025 03:52 PM EasternExtended Trading$0.89 +0.01 (+1.58%) As of 03/28/2025 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kazia Therapeutics Short Interest DataKazia Therapeutics (KZIA) has a short interest of 115,900 shares, representing 2.32% of the float (the number of shares available for trading by the public). This marks a 94.46% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 852,788 shares to cover all short positions.Current Short Interest115,900 sharesPrevious Short Interest59,600 sharesChange Vs. Previous Month+94.46%Dollar Volume Sold Short$115,343.68Short Interest Ratio0.1 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares5,036,000 sharesShort Percent of Float2.32%Today's Trading Volume69,902 sharesAverage Trading Volume852,788 sharesToday's Volume Vs. Average8% Short Selling Kazia Therapeutics? Sign up to receive the latest short interest report for Kazia Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKZIA Short Interest Over TimeKZIA Days to Cover Over TimeKZIA Percentage of Float Shorted Over Time Remove Ads Kazia Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2025115,900 shares $115,343.68 +94.5%2.3%0.1 $1.00 2/28/202559,600 shares $50,743.44 -34.1%2.1%0 $0.85 2/15/202590,500 shares $80,545.00 -90.2%3.1%0.1 $0.89 1/31/2025921,900 shares $1.46 million +7,712.7%31.7%0.5 $1.58 1/15/202511,800 shares $18,290.00 +110.7%0.4%0.1 $1.55 12/31/20245,600 shares $9,912.00 -66.7%N/A0 $1.77 12/15/202416,800 shares $59,640.00 -24.7%N/A0.1 $3.55 11/30/202422,300 shares $115,291.00 -36.3%N/A0.2 $5.17 11/15/202435,000 shares $159,950.00 +86.2%N/A0.2 $4.57 10/31/202418,800 shares $101,520.00 -88.5%N/A0.1 $5.40 Get the Latest News and Ratings for KZIA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kazia Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/15/2024164,000 shares $54,136.40 -47.4%N/A0.1 $0.33 9/30/2024311,600 shares $133,956.84 -80.5%N/A0 $0.43 9/15/20241,600,000 shares $548,960.00 +388.1%N/A0.1 $0.34 8/31/2024327,800 shares $138,757.74 -21.8%N/A0 $0.42 8/15/2024418,900 shares $161,276.50 +85.0%N/A0 $0.39 7/31/2024226,400 shares $84,447.20 -93.3%N/A0 $0.37 7/15/20243,380,000 shares $1.89 million +7,076.2%N/A0.3 $0.56 6/30/202447,100 shares $10,767.06 +97.9%N/A0 $0.23 6/15/202423,800 shares $5,475.55 -10.2%N/A0.1 $0.23 5/31/202426,500 shares $6,890.00 -45.0%N/A0.1 $0.26 5/15/202448,200 shares $13,009.18 -44.0%N/A0.1 $0.27 4/30/202486,000 shares $28,792.80 +367.4%N/A0.1 $0.33 4/15/202418,400 shares $5,648.80 -92.9%N/A0 $0.31 3/31/2024259,500 shares $80,393.10 +6.9%N/A0.3 $0.31 3/15/2024242,800 shares $54,362.92 -68.3%N/A0.3 $0.22 2/29/2024765,100 shares $195,177.01 +1,566.9%N/A1.1 $0.26 2/15/202445,900 shares $14,242.77 -74.7%N/A0.1 $0.31 1/31/2024181,700 shares $54,328.30 +54.5%N/A1 $0.30 1/15/2024117,600 shares $41,148.24 +103.1%N/A1.1 $0.35 12/31/202357,900 shares $25,447.05 +32.8%N/A0.6 $0.44 12/15/202343,600 shares $17,047.60 -40.3%N/A0.5 $0.39 11/30/202373,000 shares $40,931.10 -35.6%N/A0.9 $0.56 11/15/2023113,400 shares $87,658.20 +1,889.5%N/A1.6 $0.77 10/31/20235,700 shares $2,393.43 -95.0%N/A0.1 $0.42 10/15/2023113,800 shares $77,384.00 +116.8%N/A3.1 $0.68 9/30/202352,500 shares $52,250.63 +10.3%N/A1.3 $1.00 9/15/202347,600 shares $48,076.00 -24.3%N/A0.3 $1.01 8/31/202362,900 shares $57,245.29 +10.5%N/A0.3 $0.91 8/15/202356,900 shares $51,329.49 -33.5%N/A0.3 $0.90 7/31/202385,600 shares $86,456.00 -2.5%N/A0.5 $1.01Elon’s ‘Strike Squad’ sends these 9 stocks soaring? (Ad)Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the federal government. And that's creating a huge buying opportunity for the stocks involved. Put simply, under Elon's watchful eye, the U.S. government is rapidly adopting AI technology. And that's sending certain stocks soaring higher.Here's how to get our 9-stock buy list immediately. 7/15/202387,800 shares $76,745.98 -36.8%N/A0.5 $0.87 6/30/2023139,000 shares $158,460.00 -3.6%N/A0.8 $1.14 6/15/2023144,200 shares $181,692.00 -10.7%N/A4.7 $1.26 5/31/2023161,500 shares $192,185.00 +20.3%N/A4.8 $1.19 5/15/2023134,300 shares $178,619.00 -24.4%N/A3 $1.33 4/30/2023177,700 shares $236,341.00 +28.2%N/A3.9 $1.33 4/15/2023138,600 shares $182,952.00 -2.0%N/A2.8 $1.32 3/31/2023141,400 shares $145,656.14 +10.0%N/A2.7 $1.03 3/15/2023128,600 shares $120,768.26 -8.5%N/A2.2 $0.94 2/28/2023140,600 shares $129,352.00 -3.8%N/A2.3 $0.92 2/15/2023146,100 shares $131,490.00 -17.3%N/A2.6 $0.90 1/31/2023176,700 shares $182,001.00 -28.5%N/A2.8 $1.03 1/15/2023247,100 shares $259,455.00 +64.2%N/A0.7 $1.05 12/30/2022150,500 shares $92,542.45 -7.8%N/A0.4 $0.61 12/15/2022163,300 shares $89,145.47 -6.1%N/A0.5 $0.55 11/30/2022173,900 shares $104,966.04 -3.4%N/A0.5 $0.60 11/15/2022180,100 shares $118,866.00 -75.8%N/A0.5 $0.66 10/31/2022744,000 shares $614,767.20 +526.3%N/A2.1 $0.83 10/15/2022118,800 shares $118,800.00 +7.1%N/A0.4 $1.00 9/30/2022110,900 shares $121,990.00 -5.9%N/A0.4 $1.10 9/15/2022117,900 shares $168,597.00 -20.7%N/A0.3 $1.43 8/31/2022148,700 shares $227,511.00 -24.8%N/A0.2 $1.53 8/15/2022197,700 shares $345,975.00 +68.7%N/A0.3 $1.75 7/31/2022117,200 shares $425,436.00 -19.0%N/A0.2 $3.63 7/15/2022144,600 shares $539,358.00 +113.9%N/A0.4 $3.73 6/30/202267,600 shares $283,920.00 +90.4%N/A0.2 $4.20 6/15/202235,500 shares $191,700.00 +86.8%N/A0.1 $5.40 5/31/202219,000 shares $110,010.00 -21.2%N/A0.7 $5.79 5/15/202224,100 shares $132,309.00 +225.7%N/A1.2 $5.49 4/30/20227,400 shares $47,582.00 -53.5%N/A0.5 $6.43 4/15/202215,900 shares $121,317.00 +45.9%N/A1.2 $7.63 3/31/202210,900 shares $84,039.00 +445.0%N/A0.7 $7.71 3/15/20222,000 shares $12,100.00 -79.4%N/A0.1 $6.05 2/28/20229,700 shares $65,184.00 +592.9%N/A0.5 $6.72 2/15/20221,400 shares $10,514.00 +55.6%N/A0.1 $7.51 1/31/2022900 shares $6,030.00 -64.0%N/A0 $6.70 1/15/20222,500 shares $19,500.00 -19.4%N/A0.1 $7.80 12/31/20213,100 shares $26,102.00 -59.2%N/A0.1 $8.42 12/15/20217,600 shares $55,860.00 +20.6%N/A0.3 $7.35 11/30/20216,300 shares $63,189.00 +162.5%N/A0.2 $10.03 11/15/20212,400 shares $26,856.00 +4.4%N/A0.1 $11.19 10/29/20212,300 shares $24,909.00 -37.8%N/A0.1 $10.83 10/15/20213,700 shares $38,850.00 -67.8%N/A0.1 $10.50 9/30/202111,500 shares $130,180.00 -27.7%N/A0.5 $11.32 9/15/202115,900 shares $165,042.00 -29.0%N/A0.6 $10.38 8/31/202122,400 shares $243,040.00 +21.7%N/A0.7 $10.85 8/13/202118,400 shares $174,800.00 -18.6%N/A0.6 $9.50 7/30/202122,600 shares $204,078.00 -3.0%N/A0.6 $9.03 7/15/202123,300 shares $223,214.00 -16.5%N/A0.6 $9.58 6/30/202127,900 shares $275,094.00 +57.6%N/A0.5 $9.86Elon’s ‘Strike Squad’ sends these 9 stocks soaring? (Ad)Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the federal government. And that's creating a huge buying opportunity for the stocks involved. Put simply, under Elon's watchful eye, the U.S. government is rapidly adopting AI technology. And that's sending certain stocks soaring higher.Here's how to get our 9-stock buy list immediately. 6/15/202117,700 shares $189,921.00 -18.1%N/A0.2 $10.73 5/28/202121,600 shares $205,416.00 -14.3%N/A0.2 $9.51 5/14/202125,200 shares $239,904.00 -38.2%N/A0.2 $9.52 4/30/202140,800 shares $444,720.00 +1,175.0%N/A0.3 $10.90 4/15/20213,200 shares $36,544.00 -88.5%N/A0 $11.42 3/31/202127,700 shares $333,508.00 -27.1%N/A0.2 $12.04 3/15/202138,000 shares $417,240.00 +32.9%N/A0.3 $10.98 2/26/202128,600 shares $297,154.00 +236.5%N/A0.2 $10.39 2/12/20218,500 shares $85,850.00 -18.3%N/A0 $10.10 1/29/202110,400 shares $99,424.00 -35.0%N/A0 $9.56 1/15/202116,000 shares $164,640.00 No ChangeN/A0 $10.29 KZIA Short Interest - Frequently Asked Questions What is Kazia Therapeutics' current short interest? Short interest is the volume of Kazia Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 115,900 shares of KZIA short. 2.32% of Kazia Therapeutics' shares are currently sold short. Learn More on Kazia Therapeutics' current short interest. Which institutional investors are shorting Kazia Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Kazia Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Kazia Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.32% of Kazia Therapeutics' floating shares are currently sold short. Is Kazia Therapeutics' short interest increasing or decreasing? Kazia Therapeutics saw a increase in short interest in March. As of March 15th, there was short interest totaling 115,900 shares, an increase of 94.5% from the previous total of 59,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Kazia Therapeutics' short interest compare to its competitors? 2.32% of Kazia Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kazia Therapeutics: Eagle Pharmaceuticals, Inc. (2.90%), IN8bio, Inc. (2.58%), Mannatech, Incorporated (1.51%), Cellectar Biosciences, Inc. (6.44%), Senti Biosciences, Inc. (0.35%), Edesa Biotech, Inc. (1.61%), BioAtla, Inc. (9.86%), Chemomab Therapeutics Ltd. (1.63%), Bullfrog AI Holdings, Inc. (4.26%), Elevation Oncology, Inc. (16.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Kazia Therapeutics stock? Short selling KZIA is an investing strategy that aims to generate trading profit from Kazia Therapeutics as its price is falling. KZIA shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kazia Therapeutics? A short squeeze for Kazia Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KZIA, which in turn drives the price of the stock up even further. How often is Kazia Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KZIA, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies EGRX Short Squeeze INAB Short Squeeze MTEX Short Squeeze CLRB Short Squeeze SNTI Short Squeeze EDSA Short Squeeze BCAB Short Squeeze CMMB Short Squeeze BFRG Short Squeeze ELEV Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KZIA) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump's 100-Day Plan Triggers Global RetaliationIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredCrypto Genius: 12,000% in 12 months? [Here’s how]We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kazia Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Kazia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KZIA Stock Free KZIA Stock Alerts